# PharmaAI implementation and manual acceptance handoff

Date: 30 October 2026. **Core development implementation is present; full MVP acceptance is not complete.** The user requested building the remaining work and testing manually, so full automated suites were paused and preserved. A successful build is not a business acceptance pass.

## Implemented

- Existing Clerk Google sign-in and current organization/role/unit/distributor authorization; invitation/event interfaces and development-only MFA exception.
- Persistent manufacturer setup, products, units, distributors, versioned templates/policies/tolerances/deadlines and append-only history.
- Exact quantities/rates and safe integer-paise money; protected uploads, bounded parsing/validation, human correction/confirmation, source versions and resumable linking.
- Stable return cases, manufacturer receipt/photos, policy-based eligibility, human approval/rejection/clarification and reviewer assignment. Finance worklist, actual issued-credit entry/import, note-header confirmation, allocation corrections and exact/partial/excess matching.
- Monthly stock reports, independent manufacturer receipts, first-opening confirmation/prior closing carry, full stock equation, tolerance/valuation, correction/adjustment/escalation/carry-forward/resolution.
- Shared team queue with ownership, deadlines, priority, recurrence, source-change reopening, internal comments and protected evidence references.
- Scoped Overview/reports, source drill-through, permission-controlled CSV export, audit and historical calculation inspection, in-app alerts/preferences and basic operational health.
- Configured-only advisory AI with checked image/PDF extraction, cited explanations/priorities, controlled management questions, human extraction confirmation/prefill, caching, usage reservations and manual fallbacks.

Original evidence, prior calculations and consequential human reasons remain retained. No real client data, new provider account, real-person notification or AI request was introduced by this implementation. Approved screenshot references and unrelated `artifacts/` and `outputs/` remain intact.

## Verification evidence

Final command output (also recorded in `PROGRESS.md`):

```text
npm run lint                              exit 0; no warnings/errors
npm run typecheck                         exit 0
npm run build                             exit 0; compiled in 5.6s; TypeScript 8.9s; 6/6 pages
npx convex dev --once --tail-logs disable   exit 0; Convex functions ready (10.13s)
git diff --check                          exit 0
Local preview availability                HTTP 200
```

 Basic lint, TypeScript, Webpack compilation/page generation and Convex development function preparation were run. Full unit/integration/browser suites were not rerun after the user changed the verification approach. No business workflow is described as manually passed.

Historical evidence only, predating the latest business code:

- Phase 3: 40 unit, 49 integration and 40 browser checks passed; a subsequent focused authenticated run reported 17 passed.
- Phase 4: 63 unit and 64 integration checks passed before later field additions.
- The in-progress browser run was interrupted by request: 39 passed, 1 interrupted, 2 not run; exit 130. This is not a passing suite.

## PLAN section 24 — Definition of Done

`FAIL / unverified` means the complete acceptance criterion has not been demonstrated. It does not assert that every implementation beneath that criterion is broken.

| Item | Status | Evidence and remaining requirement |
|---|---|---|
| 1. Configure organization, products, distributors, templates, policies, deadlines and team | FAIL / unverified | Persistent configuration operations and existing screens are wired; earlier configuration integration checks are narrower than current full setup. Manual setup/reload/denial acceptance remains unchecked. |
| 2. Invite internal and restricted distributor users | FAIL / unverified | Scoped invitation preparation/delivery/acceptance code and prior genuine-session checks exist. External receipt, real identity-event activation and live MFA remain gates. |
| 3. Return through receipt, eligibility, approval, credit and closure | FAIL / unverified | `returns`, `credits`, `documents`, immutable runs and connected case/Finance controls implemented. A complete live-file workflow is blocked by scanning and awaits manual acceptance. |
| 4. Monthly report through validation, calculation, investigation and resolution | FAIL / unverified | `stock`, `compliance`, immutable adjustments/actions and connected list/detail implemented. Representative files, first opening, zero-receipt coverage and source corrections need manual acceptance. |
| 5. AI extraction, matching, explanation, priority, confidence, correction and citations | FAIL / unverified | Structured output/citation validation, configured-only provider, usage reservations and confirmed extraction linkage implemented. Approved model/key, scanner, real output validation and accuracy acceptance remain absent. Management questions are controlled choices. |
| 6. Route exceptions through the shared queue | FAIL / unverified | Stable fingerprints, team/current-scope checks, assignment, due dates, discussion and reopening implemented. Multi-role manual routing/reopening acceptance remains unchecked. |
| 7. Scoped reports and audit history | FAIL / unverified | Saved-result aggregates, protected CSV export, scope-filtered audit and historical snapshots implemented. Totals/export denial/source tracing require manual acceptance. |
| 8. Supported widths and keyboard use | FAIL / unverified | Existing responsive layouts retained, new controls use accessible labels/focus patterns and overflow containers. Connected panels/reference comparison/browser matrix were not rerun. |
| 9. Safe invalid-data, AI, interruption, duplicate and permission recovery | FAIL / unverified | Stable keys, file/job recovery, source versions, reauthorization and uncertain-AI fallback implemented. New failure/retry scenarios require acceptance; earlier access checks do not certify them. |
| 10. Lint, types, tests, accessibility, browsers and production build | FAIL / unverified | Basic compilation checks pass at recorded checkpoints. Full current suites, accessibility/browser, recovery and production readiness are deliberately unverified under the user's instruction. |

## Blockers and limits

1. Automated malware/DLP scanning was removed from the MVP by explicit product decision and is deferred in `todo.md`; production security review may require reconsideration.
2. Advisory AI needs an approved model/key and enabled organization usage settings. No silent model fallback. Reservations are estimates, not provider invoice caps.
3. Native Clerk MFA/reverification, actual event registration/delivery and observed invitation receipt remain production/security gates. The MFA exception is development-only.
4. Manual acceptance is pending. Real client-data use, region/privacy/retention/contracts, external monitoring and backup/restore approval remain blocked.
5. Pilot limits are explicit in README/operations. Historical audit/runs show bounded recent lists; older immutable data is retained. Arbitrary management questions and cross-year comparisons are not implemented. A zero-receipt period without independent manufacturer coverage remains incomplete rather than guessed as zero.
6. Only in-app reminders are enabled. Email/SMS/WhatsApp integrations and deep ERP/DMS connections remain deferred.

## Changes and recovery

The work stays in the same VS Code repository. Recoverable checkpoints include `c8e224f` (foundation), `66d2172` (intake), `c5e6676` (returns/stock) and `00440af` (queue/reports/AI). This report and operations guidance are included in the final cleanup/documentation checkpoint. No source/design files were deleted; obsolete generic simulation handlers and duplicate fixed-zero business cards were removed after their replacements were saved. Tests were preserved unchanged during the manual-first implementation.

Preview: `npm run dev` at http://localhost:3000; keep `npx convex dev` in the second terminal for backend development. Use `MANUAL_TESTING.md`; consult `OPERATIONS.md` for blocked jobs and release gates. No production website or GitHub push is implied by these local commits.

## Remaining PLAN section 25 risks

All require industry/pilot validation: financial and operational value; distributor report availability/reliability; enforcing templates/deadlines; actual invoice/return/credit flow; physical-receipt ownership; policy structure; credit grouping/Finance practices; existing ERP/DMS/SANeForce/Pharmarack coverage/exportability; representative formats/volumes/performance; AI accuracy/correction burden; retention/privacy/contracts/AI processing; buyer/budget/switching cost and measurable pilot success. These remain assumptions, not verified customer facts.
